Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 30;6(1):e966.
doi: 10.1002/hsr2.966. eCollection 2023 Jan.

Respiratory support of adults in the emergency department: A protocol for a prospective, observational, multicenter point prevalence study

Affiliations

Respiratory support of adults in the emergency department: A protocol for a prospective, observational, multicenter point prevalence study

Jane O'Donnell et al. Health Sci Rep. .

Abstract

Background and aims: Providing respiratory support (RS) to patients may improve their oxygenation and ventilation, reducing the work of breathing. Emergency department (ED) patients often need RS; COVID-19 has heightened this need. Patients receiving RS may need escalation of their treatment; hence, studies considering the prevalence of escalation are warranted.

Method: This is a protocol for a prospective, observational, multicenter point prevalence study (PPS). Researchers will collect data over 2 days. All participants are adult ED patients needing RS. The setting is four EDs in New Zealand. The primary research question asks, "Which patients receiving RS require escalation of therapy in the ED?" For example, transitioning from conventional oxygen therapy (COT) to intubation is deemed an escalation of therapy. A sample size of 80 participants is required to resolve the primary research question. Secondary research questions: (1) Which patients receive nasal high flow (NHF) in the ED? (2) How is NHF therapy delivered in the ED? (3) What are the effects of NHF therapy on physiological and patient-centered outcomes? Research Electronic Data Capture (REDCap) will be used for data organization. Data will be imported for analysis from REDCap to IBM SPSS software (Statistics for Windows, Version 27.0). Data reporting on the primary outcome shall be considered by analysis of variance, regression modeling, and determination of two treatment effects: Odds Ratio and Number Needed to Treat. Statistical significance for inferential statistics shall use a two-sided α with p-values fixed at ≤0.05 level of significance and 95% confidence intervals. This protocol has ethical approval from Massey University, New Zealand.

Conclusion: This novel PPS may reduce the evidence and clinical practice gap on RS delivery and ED patient outcomes, as evidenced by the emergence of COVID-19.

Keywords: COVID 19; emergency; nasal high flow; point prevalence; respiratory support.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Study procedural phases and steps. aElectronic case report form; bemergency department.
Figure 2
Figure 2
Triggers for escalation of care in the emergency department

Similar articles

References

    1. Marjanovic N, Guénézan J, Frat JP, Mimoz O, Thille AW. High‐flow nasal cannula oxygen therapy in acute respiratory failure at emergency departments: a systematic review. Am J Emerg Med. 2020;38(7):1508‐1514. 10.1016/j.ajem.2020.04.091 - DOI - PubMed
    1. Raven MC, Lowe RA, Maselli J, Hsia RY. Comparison of presenting complaint vs discharge diagnosis for identifying “nonemergency” emergency department visits. JAMA. 2013;309(11):1145‐1153. 10.1001/jama.2013.1948 - DOI - PMC - PubMed
    1. Kelly AM, Keijzers G, Klim S, et al. An observational study of dyspnea in emergency departments: the Asia, Australia, and New Zealand Dyspnea in Emergency Departments Study (AANZDEM). Acad Emerg Med. 2017;24(3):328‐336. 10.1111/acem.13118 - DOI - PubMed
    1. Marjanovic N, Flacher A, Drouet L, et al. High‐flow nasal cannula in early emergency department management of acute hypercapnic respiratory failure due to cardiogenic pulmonary edema. Respir Care. 2020;65(9):1241‐1249. 10.4187/respcare.07278 - DOI - PubMed
    1. Ischaki E, Pantazopoulos I, Zakynthinos S. Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device. Eur Respir Rev. 2017;26(145):170028. 10.1183/16000617.0028-2017 - DOI - PMC - PubMed

LinkOut - more resources